Meetings & Events

Updates in Osteoporosis Treatment

June 16, 2021

Session Date and Time:

Friday, September 10
1:15–2:00 PM EDT

Learning Objectives:

  1. Recognize potential causes and contributors to the current crises in osteoporosis care.
  2. Assess the relative efficacy and limitations of anabolic and antiresorptive osteoporosis therapies.
  3. Summarize the relative efficacy of various sequential and combination approaches to osteoporosis management.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Benjamin Leder, MDDr. Leder received his medical degree from Harvard Medical School and completed his Internal Medicine Residency and Endocrine Fellowship at Massachusetts General Hospital, where he has remained ever since. His current position is Professor of Medicine at Harvard Medical School.

Over the past two decades, Dr. Leder has been both an active clinician (serving as the Director of Endocrine Associates, a 16-physician practice focusing on metabolic bone disease) and clinical investigator. His NIH-funded research focuses on developing novel therapeutic approaches to the management of postmenopausal osteoporosis and other metabolic bone diseases.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.